See my post of yesterday:
I am a major investor in this and just voted for my shares. I am too lazy to study them anymore. I think that they can do much better than this. They should re-negotiate their royalties with Roch. I hate the big pharma. they are like Mafia. I think that CRIS will have at least one approval in Q2. Their Q1 should be very good and will see that end of this month. Genentech will present the clinical phase 1 data on the new compound before Q3. I also hope that the clinical data for Erivedge will be out soon. That is doing very good.
Since you read tea leaves what about RCON, RCON has a quarterly report in 10 days and should run on that an in fact has started to head up after accumulation phase. Lets have a good tea leaf read on that and see if you call it correctly?